NO20093384L - Sykdomsmarkorer - Google Patents

Sykdomsmarkorer

Info

Publication number
NO20093384L
NO20093384L NO20093384A NO20093384A NO20093384L NO 20093384 L NO20093384 L NO 20093384L NO 20093384 A NO20093384 A NO 20093384A NO 20093384 A NO20093384 A NO 20093384A NO 20093384 L NO20093384 L NO 20093384L
Authority
NO
Norway
Prior art keywords
autoimmune disease
sykdomsmarkorer
biomarkers
cytokine
kits
Prior art date
Application number
NO20093384A
Other languages
English (en)
Inventor
David Wraith
Heather Streeter
Original Assignee
Apitope Technology Bristol Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apitope Technology Bristol Ltd filed Critical Apitope Technology Bristol Ltd
Publication of NO20093384L publication Critical patent/NO20093384L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/285—Demyelinating diseases; Multipel sclerosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Den foreliggende oppfinnelse vedrører biomarkører for autoimmun sykdom og vedrører spesielt en fremgangsmåte for å bestemme en status til en autoimmun sykdom i et testindivid, som omfatter å måle produksjon av et Th2 cytokin ved hjelp av leukocytter fra individet, så vel som assosierte anvendelser og kit.
NO20093384A 2007-04-24 2009-11-19 Sykdomsmarkorer NO20093384L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0707933.8A GB0707933D0 (en) 2007-04-24 2007-04-24 Disease markers
PCT/GB2008/001415 WO2008129296A2 (en) 2007-04-24 2008-04-23 Disease markers

Publications (1)

Publication Number Publication Date
NO20093384L true NO20093384L (no) 2010-01-18

Family

ID=38135366

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20093384A NO20093384L (no) 2007-04-24 2009-11-19 Sykdomsmarkorer

Country Status (13)

Country Link
US (1) US20100129853A1 (no)
EP (1) EP2156190A2 (no)
JP (1) JP2010525355A (no)
CN (1) CN102317787A (no)
AU (1) AU2008240367A1 (no)
BR (1) BRPI0810559A2 (no)
CA (1) CA2685113A1 (no)
GB (1) GB0707933D0 (no)
MX (1) MX2009011494A (no)
NO (1) NO20093384L (no)
PL (1) PL391035A1 (no)
RU (1) RU2009142935A (no)
WO (1) WO2008129296A2 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7381535B2 (en) 2002-07-10 2008-06-03 The Board Of Trustees Of The Leland Stanford Junior Methods and compositions for detecting receptor-ligand interactions in single cells
KR20220008944A (ko) 2008-01-18 2022-01-21 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 체액 내에서 질병 또는 병태의 시그너쳐의 검출 방법
GB0903391D0 (en) * 2009-02-27 2009-04-08 Cambridge Entpr Biomarkers
EP2539470B1 (en) * 2010-02-24 2017-02-22 The Board of Trustees of The Leland Stanford Junior University Methods for autoimmune disease diagnosis, prognosis, and treatment
JP2013538565A (ja) 2010-07-23 2013-10-17 プレジデント アンド フェロウズ オブ ハーバード カレッジ 体液中の疾患または症状のシグネチャを検出する方法
WO2012012725A2 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting diseases or conditions using phagocytic cells
CA2806304A1 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting prenatal or pregnancy-related diseases or conditions
US20130184178A1 (en) 2010-07-23 2013-07-18 President And Fellows Of Harvard College Methods of Detecting Autoimmune or Immune-Related Diseases or Conditions
EP2965077B1 (en) 2013-03-09 2022-07-13 Harry Stylli Methods of detecting cancer
EP2965086A4 (en) 2013-03-09 2017-02-08 Harry Stylli Methods of detecting prostate cancer
GB201400562D0 (en) 2014-01-14 2014-03-05 Orla Protein Technologies Ltd Protein coated polymeric substrate
EP3191846A4 (en) 2014-09-11 2018-06-13 Harry Stylli Methods of detecting prostate cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1546719E (pt) * 2002-08-08 2015-07-02 Baylor College Medicine Isolamento e identificação de células t
ATE491953T1 (de) * 2003-09-15 2011-01-15 Oklahoma Med Res Found Verfahren zur verwendung von cytokintests zur diagnose, behandlung und beurteilung von ankyloider spondylitis

Also Published As

Publication number Publication date
WO2008129296A2 (en) 2008-10-30
CN102317787A (zh) 2012-01-11
MX2009011494A (es) 2009-11-09
AU2008240367A1 (en) 2008-10-30
BRPI0810559A2 (pt) 2015-02-10
WO2008129296A3 (en) 2008-12-11
RU2009142935A (ru) 2011-05-27
JP2010525355A (ja) 2010-07-22
PL391035A1 (pl) 2010-10-25
US20100129853A1 (en) 2010-05-27
GB0707933D0 (en) 2007-05-30
CA2685113A1 (en) 2008-10-30
EP2156190A2 (en) 2010-02-24

Similar Documents

Publication Publication Date Title
NO20093384L (no) Sykdomsmarkorer
EA201290311A1 (ru) Факторы риска и прогнозирование инфаркта миокарда
WO2009083950A3 (en) Biomarkers for the prediction of renal injury
EA201270020A1 (ru) Определение риска развития атеросклеротической болезни сердца
WO2007062090A3 (en) Methods and compositions related to b cell assays
EA201600085A1 (ru) Набор для обнаружения соевого события syht0h2
GB2474146A (en) Methods of determining the health status of an individual
DK1826279T3 (da) Detektering og kvalitetskontrol af regulatoriske t-celler vha. DNA-metyleringsanalyse af FoxP3--genet
EA200801046A1 (ru) Неинвазивный способ выявления переходно-клеточной карциномы мочевого пузыря in vitro
EP2261367A3 (en) Gene expression markers for inflammatory bowel disease
WO2012120288A3 (en) Method, array and use for determining the presence of pancreatic cancer.
WO2010068686A3 (en) Methods of diagnosing and predicting renal disease
WO2009108905A3 (en) Fluorescence polarization herg assay
EA200802169A1 (ru) Способы анализа гидроксикарбоната лантана
DK2449370T3 (da) Analyse og test af glykerede hæmoglobiner ved kapillær elektroforese, buffersammensætninger og sæt til kapillær elektroforese
NO20073680L (no) Fremgangsmate for a analysere data som har felles og saerskilte egenskaper
RU2011116763A (ru) Способ количественного определения термического стресса, которому подвергался фруктовый сок
DK2021794T3 (da) Anvendelse af protein S100A 12 som en markør for colorektal cancer
GB201305388D0 (en) Benchmarks for normal cell identification
NO20073508L (no) Anordninger og fremgangsmåter for formasjonstesting ved trykkmåling i et isolert, variabelt volum
HK1165001A1 (zh) 利用免疫法測定生物樣品中的雌馬酚的方法、用於該測定的試劑盒、以及判定受試者的雌馬酚產生能力的方法
EA201171178A1 (ru) Устройство и способ для определения и количественного анализа аналитов, в частности, микотоксинов
WO2010087594A3 (ko) 시디９３ 또는 이의 가용성 단편의 용도
EP2075341A4 (en) METHOD FOR THE INVESTIGATION, DETERMINATION OR EVALUATION BY MEANS OF GENE EXPRESSION ANALYSIS
ATE500503T1 (de) Cd86- und cd80-rezeptorkonkurrenztests

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application